1. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB de O, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. Springer US; 2022.
2. Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. Blood. 2022.
3. Swerdlow S, Campo E, Harris N, Al E. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4t. Lyon, France: IARC; 2017.
4. Melo J V., Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: II. patterns of evolution of ‘prolymphocytoid’ transformation. Br J Haematol. 1986;64:77–86.
5. Cartron G, Linassier C, Bremond JL, Desablens B, Georget MT, Fimbel B, et al. CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases. Leuk Lymphoma. 1998;31:209–16.